![Shan Yin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Shan Yin
Direktor/Vorstandsmitglied bei OBIO TECHNOLOGY (SHANGHAI) CORP., LTD.
Ursprung des Netzwerks ersten Grades von Shan Yin
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 16 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Shan Yin
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
The University of Edinburgh | College/University | Graduate Degree | |
University of California San Diego | College/University | Undergraduate Degree | |
Shanghai University of Finance & Economics
![]() Shanghai University of Finance & Economics Other Consumer ServicesConsumer Services Shanghai University of Finance and Economics engages in the provision of educational services. It offers courses under the following school and departments: business, accountancy, finance, international business administration, economics, public economics and administration, humanities, law, information management and engineering, statistics, foreign languages, mathematics, international cultural exchange, professional and international education and continuing education. The company was founded in 1917 and is headquartered in Shanghai, China. | College/University | Undergraduate Degree | |
Shanghai Genon Biological Product Co., Ltd.
![]() Shanghai Genon Biological Product Co., Ltd. BiotechnologyHealth Technology Shanghai Genon Biological Product Co., Ltd. engages in the research and development, manufacture, and sale of animal-derived protein and biological products. Its products include plasma series, blood cell series, and peptide series. Its business scope includes production of animal-derived feed products such as plasma protein powder, hemoglobin powder, and intestinal membrane protein powder; sale of concentrated feed. The company was founded on July 21, 2005 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
Dartmouth Medical School | College/University | Doctorate Degree | |
SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Shanghai Senyu Media Holding Co., Ltd.
![]() Shanghai Senyu Media Holding Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Senyu Media Holding Co., Ltd. engages in the copyright trading and co-operating with radio and television network, media operators, and new media. The company was founded on August 5, 2010 and is headquartered in Shanghai, China. | Miscellaneous Commercial Services | Director/Board Member | |
Shenzhen Sinaean Co Tech Energy Technology Co., Ltd.
![]() Shenzhen Sinaean Co Tech Energy Technology Co., Ltd. Electrical ProductsProducer Manufacturing Shenzhen Sinaean Co Tech Energy Technology Co., Ltd. operates a thermal power plant. The private company is based in Shenzhen, China. | Electrical Products | Director/Board Member | |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Director/Board Member | |
Hrain Biotechnology Co., Ltd.
![]() Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
3D MEDICINES INC. | Pharmaceuticals: Major | Director/Board Member | |
Shanghai Vitalgen Biopharma Co., Ltd.
![]() Shanghai Vitalgen Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Vitalgen Biopharma Co., Ltd. is a company based in Shanghai, China that engages in drug research and development services. The Chinese company was founded in 2020. The CEO is Xiao Ping Zhao. | Miscellaneous Commercial Services | Director/Board Member | |
GUOSEN SECURITIES CO., LTD. | Investment Banks/Brokers | Corporate Officer/Principal |
Statistik
International
China | 11 |
Vereinigte Staaten | 3 |
Vereinigtes Königreich | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 5 |
Commercial Services | 3 |
Producer Manufacturing | 2 |
Finance | 2 |
Operativ
Director/Board Member | 22 |
Independent Dir/Board Member | 5 |
Corporate Officer/Principal | 5 |
Chief Executive Officer | 2 |
Chairman | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Pai Zhu | 6 |
Gang Wang | 4 |
Lu Yuan Xu | 2 |
Yuan Yuan Xu | 2 |
Li Ning Gan | 2 |
Ke Jia Yuan | 2 |
Xiao Gao | 2 |
Rui Dong Pan | 1 |
Guo Dong Jia | 1 |
Zheng Qi Song | 1 |
Fu Jie Wang | 1 |
Si Jie Song | 1 |
Jun Yi Pan | 1 |
Long Xia | 1 |
Zhao Rui Song | 1 |